Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma
This study is ongoing, but not recruiting participants.
Study NCT00006357 Information provided by National Cancer Institute (NCI)
First Received: October 4, 2000 Last Updated: May 7, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Endometrial Cancer
Gastrointestinal Stromal Tumor
Ovarian Cancer
Sarcoma
Small Intestine Cancer
Additional conditions recognized in this trial
Duodenal Neoplasms
Endometrial Neoplasms
Gastrointestinal Stromal Tumors
Ileal Neoplasms
Intestinal Neoplasms
Jejunal Neoplasms
Ovarian Neoplasms
More general conditions related to this trial
Adnexal Diseases
Digestive System Diseases
Digestive System Neoplasms
Duodenal Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Ileal Diseases
Intestinal Diseases
Jejunal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Ovarian Diseases
Urogenital Neoplasms
Uterine Diseases
Uterine Neoplasms
Interventions listed in this trial
imatinib mesylate
Additional drug interventions recognized in this trial
Imatinib
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
European Organization for Research and Treatment of Cancer
Back to top of Main Content